JP2004002414A5 - - Google Patents

Download PDF

Info

Publication number
JP2004002414A5
JP2004002414A5 JP2003132491A JP2003132491A JP2004002414A5 JP 2004002414 A5 JP2004002414 A5 JP 2004002414A5 JP 2003132491 A JP2003132491 A JP 2003132491A JP 2003132491 A JP2003132491 A JP 2003132491A JP 2004002414 A5 JP2004002414 A5 JP 2004002414A5
Authority
JP
Japan
Prior art keywords
group
formula
salt
substituted
cyclo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003132491A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004002414A (ja
Filing date
Publication date
Priority claimed from AUPP8180A external-priority patent/AUPP818099A0/en
Application filed filed Critical
Publication of JP2004002414A publication Critical patent/JP2004002414A/ja
Publication of JP2004002414A5 publication Critical patent/JP2004002414A5/ja
Withdrawn legal-status Critical Current

Links

JP2003132491A 1999-01-14 2003-05-12 アミド化合物 Withdrawn JP2004002414A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP8180A AUPP818099A0 (en) 1999-01-14 1999-01-14 New n-containing heterocyclic compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000593579A Division JP3617454B2 (ja) 1999-01-14 2000-01-06 アミド化合物

Publications (2)

Publication Number Publication Date
JP2004002414A JP2004002414A (ja) 2004-01-08
JP2004002414A5 true JP2004002414A5 (enExample) 2006-06-15

Family

ID=3812385

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000593579A Expired - Lifetime JP3617454B2 (ja) 1999-01-14 2000-01-06 アミド化合物
JP2003132491A Withdrawn JP2004002414A (ja) 1999-01-14 2003-05-12 アミド化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000593579A Expired - Lifetime JP3617454B2 (ja) 1999-01-14 2000-01-06 アミド化合物

Country Status (21)

Country Link
US (2) US6710043B1 (enExample)
EP (1) EP1140836B1 (enExample)
JP (2) JP3617454B2 (enExample)
KR (2) KR100525809B1 (enExample)
CN (1) CN1142910C (enExample)
AR (1) AR028812A1 (enExample)
AT (1) ATE502923T1 (enExample)
AU (1) AUPP818099A0 (enExample)
BR (1) BRPI0008753B8 (enExample)
CA (1) CA2360360C (enExample)
CZ (1) CZ20012562A3 (enExample)
DE (1) DE60045759D1 (enExample)
ES (1) ES2363492T3 (enExample)
HK (1) HK1044337B (enExample)
HU (1) HU230422B1 (enExample)
IL (2) IL143841A0 (enExample)
RU (1) RU2208608C2 (enExample)
TR (1) TR200102038T2 (enExample)
TW (1) TWI229075B (enExample)
WO (1) WO2000042011A1 (enExample)
ZA (1) ZA200104713B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344358B1 (en) * 1999-05-28 2002-02-05 Fujisawa Pharmaceutical Co., Ltd. Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
UY27003A1 (es) 2000-11-06 2002-07-31 Schering Ag Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer
JPWO2002045715A1 (ja) * 2000-12-07 2004-04-08 藤沢薬品工業株式会社 抗痴呆効果増強剤
AU2002360561A1 (en) * 2001-12-11 2003-06-23 Sepracor, Inc. 4-substituted piperidines, and methods of use thereof
MXPA05005982A (es) * 2002-12-06 2005-08-19 Dow Agrosciences Llc Composiciones sinergicas.
US20050026844A1 (en) 2003-04-03 2005-02-03 Regents Of The University Of California Inhibitors for the soluble epoxide hydrolase
EP1765311A4 (en) 2004-03-16 2009-04-29 Univ California REDUCTION OF NEPHROPATHY WITH INHIBITORS OF SOLUBLE EPOXY HYDROLASE AND EPOXYEICOSANOIDS
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
CA2584342C (en) 2004-10-20 2013-04-30 The Regents Of The University Of California Improved inhibitors for the soluble epoxide hydrolase
EP1807390A4 (en) * 2004-11-04 2008-07-02 Neurogen Corp ARYL ALKYL UREA AS CB1 ANTAGONISTS
HRP20100542T1 (hr) 2005-09-16 2010-11-30 Arrow Therapeutics Limited Derivati bifenila i njihova uporaba za liječenje hepatitisa c
AR059826A1 (es) * 2006-03-13 2008-04-30 Univ California Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
WO2007110449A1 (en) 2006-03-29 2007-10-04 Euro-Celtique S.A. Benzenesulfonamide compounds and their use
WO2007118853A1 (en) 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and their use as blockers of calcium channels
TW200812963A (en) 2006-04-13 2008-03-16 Euro Celtique Sa Benzenesulfonamide compounds and the use thereof
JP2010507587A (ja) * 2006-10-20 2010-03-11 アレテ セラピューティクス， インコーポレイテッド 可溶性エポキシドヒドロラーゼ阻害剤
MX2009004089A (es) * 2006-10-20 2009-07-10 Arete Therapeutics Inc Inhibidores de epoxido hidrolasa soluble.
GB0706793D0 (en) * 2007-04-05 2007-05-16 Evotec Ag Compounds
WO2008124118A1 (en) 2007-04-09 2008-10-16 Purdue Pharma L.P. Benzenesulfonyl compounds and the use therof
EP2157082B1 (en) 2007-04-20 2016-06-08 Senju Pharmaceutical Co., Ltd. Neurite formation promoter
WO2009040659A2 (en) 2007-09-28 2009-04-02 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
JP5555635B2 (ja) 2007-11-05 2014-07-23 ノバルティス アーゲー 高脂血症または動脈硬化症などの疾患の処置に有用なｃｅｔｐ阻害剤としての４−ベンジルアミノ−１−カルボキシアシル−ピペリジン誘導体
ES2425776T3 (es) 2007-12-03 2013-10-17 Novartis Ag Derivados 1,2-disustituidos de 4-bencilamino-pirrolidina como inhibidores CETP útiles para el tratamiento de enfermedades tales como hiperlipidemia o arteriosclerosis
GB0813142D0 (en) 2008-07-17 2008-08-27 Glaxo Group Ltd Novel compounds
GB0813144D0 (en) 2008-07-17 2008-08-27 Glaxo Group Ltd Novel compounds
WO2011060321A1 (en) 2009-11-16 2011-05-19 Chdi, Inc. Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
EP2528604B1 (en) 2010-01-29 2017-11-22 The Regents of the University of California Acyl piperidine inhibitors of soluble epoxide hydrolase
US8889716B2 (en) 2011-05-10 2014-11-18 Chdi Foundation, Inc. Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4939679B1 (enExample) * 1969-06-30 1974-10-28
US3647805A (en) 1969-07-11 1972-03-07 Kyorin Seiyaku Kk Benzoylamino substituted 1-benzoyl-piperidines
BE791501A (fr) * 1971-11-19 1973-05-17 Albert Ag Chem Werke Diamines cycliques n,n'-disubstituees et leur procede de preparation
GB1416872A (en) * 1972-03-10 1975-12-10 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
JPS5152176A (enExample) * 1974-10-12 1976-05-08 Yoshitomi Pharmaceutical
DE2860314D1 (en) * 1977-11-24 1981-02-19 Synthelabo Derivatives of naphthalene, process for their preparation and their therapeutic application
DE3544244A1 (de) * 1985-12-14 1987-06-25 Minnesota Mining & Mfg Vorrichtung zum entnehmen von fuellgut aus beuteln
US4886809A (en) * 1986-07-31 1989-12-12 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof
CA1322199C (en) * 1987-07-15 1993-09-14 Masami Eigyo N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 ４−アミノピリジン誘導体及びその酸付加塩
US5346907A (en) * 1988-04-05 1994-09-13 Abbott Laboratories Amino acid analog CCK antagonists
GB8917687D0 (en) * 1989-08-02 1989-09-20 Fujisawa Pharmaceutical Co Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
RU2024507C1 (ru) * 1991-11-18 1994-12-15 Евгений Яковлевич Левитин 5-хлор-2-пиридиламид-4-нитро-n-(карбоксиметил)антраниловой кислоты, проявляющий противовоспалительную активность
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
KR100238346B1 (ko) * 1993-04-07 2000-03-02 오쓰까 아끼히꼬 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제
CA2123728A1 (en) * 1993-05-21 1994-11-22 Noriyoshi Sueda Urea derivatives and their use as acat inhibitors
DE4319038A1 (de) * 1993-06-08 1994-12-15 Bayer Ag Verwendung von teilweise bekannten substituierten Chromanen als Arzneimittel, neue Wirkstoffe und Verfahren zu ihrer Herstellung
ATE204264T1 (de) * 1993-06-18 2001-09-15 Fujisawa Pharmaceutical Co Zwischenprodukt zur verwendung in der synthese und verfahren zur herstellung eines aminopiperazinderivates
US5500423A (en) * 1994-09-09 1996-03-19 Hoechst-Roussel Pharmaceuticals Inc. 5,6-dihydro-4H-imidazo[4,5,1-ij]quinolines
MX9707561A (es) * 1995-04-07 1997-12-31 Schering Corp Compuestos de carbonil piperazinilo y piperidinilo.
GB9519077D0 (en) 1995-09-18 1995-11-15 Fujisawa Pharmaceutical Co New heterocyclic compounds
EP0873117A4 (en) * 1995-11-13 1999-02-24 Smithkline Beecham Corp HEMOREGULATORY CONNECTIONS
FR2744449B1 (fr) * 1996-02-02 1998-04-24 Pf Medicament Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
ZA9710872B (en) * 1996-12-12 1998-06-15 Fujisawa Pharmaceutical Co N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate.
KR20000057303A (ko) * 1996-12-24 2000-09-15 후지야마 아키라 아미노피페라진 유도체의 신규 용도
EP0968201A2 (en) * 1997-02-17 2000-01-05 Fujisawa Pharmaceutical Co., Ltd. New aminopiperazine derivatives
US6344358B1 (en) * 1999-05-28 2002-02-05 Fujisawa Pharmaceutical Co., Ltd. Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property

Similar Documents

Publication Publication Date Title
JP2004002414A5 (enExample)
AU2004298456B2 (en) Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
CN110240596B (zh) 用于治疗hbv感染的治疗剂
RU2001122727A (ru) Амиды кислот, способ их получения и фармацевтическая композиция на их основе
US6232327B1 (en) Indolyl-3-glyoxylic acid derivatives having antitumor action
US6818646B2 (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
EP4001276B1 (en) Aurora kinase inhibitor and use thereof
KR101963946B1 (ko) 카로테노이드 유도체, 그 약학상 허용되는 염 또는 그 약학상 허용되는 에스테르류 혹은 아미드류
KR920002603A (ko) 피라졸로 피리딘 화합물 및 그 제조방법
EP1137642B1 (en) Bis-sulfonamides
UA85871C2 (uk) Інгібітори дипептидилпептидази
JP2004517128A5 (enExample)
JP2006523193A5 (enExample)
CN112110938B (zh) 一种作为蛋白质激酶抑制剂的化合物及其制备方法和用途
JP2004532240A5 (enExample)
RU2000100785A (ru) Пиримидиноновые соединения, фармацевтические композиции, содержащие эти соединения, и способ их получения
JP2004517130A5 (enExample)
DE60105610D1 (en) Pyrazinonderivate
BRPI0717089A2 (pt) Derivados de quinolinona
CA2354213A1 (en) N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity
JP2002053577A5 (enExample)
CA1257261A (en) 4-alkoxy-pyrido[2,3-d]pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them
EP0257616B1 (en) Dihydropyridine derivates and pharmaceutical composition thereof
JPH08501287A (ja) アミド誘導体
CA2039937A1 (fr) Derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent